stockrowBeOne Medicines Ltd. - Sponsored ADR (ONC) vs Roivant Sciences Ltd. (ROIV)
- BeOne Medicines Ltd. - Sponsored ADR ONC 408.03 +5.37%
- Roivant Sciences Ltd. ROIV 38.70 +5.68%
BeOne Medicines Ltd. - Sponsored ADR and Roivant Sciences Ltd. are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $40.4B against $26.5B — 1.5× the size. Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; BeOne Medicines Ltd. - Sponsored ADR trades at 65.9×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 32.9% against −67.6%. BeOne Medicines Ltd. - Sponsored ADR has the higher net margin (13.9% vs −3,535.0%) and the higher return on invested capital (85.2% vs −34.5%). Across the 18 metrics below, BeOne Medicines Ltd. - Sponsored ADR leads on 15 and Roivant Sciences Ltd. on 3.
Valuation
Profitability
| Metric | ONC | ROIV | Biotechnology median |
|---|---|---|---|
| Gross margin | 89.39% | 81.21% | 65.16% |
| Operating margin | 17.84% | (7,914.75%) | 0.00% |
| Net margin | 13.86% | (3,534.96%) | 0.00% |
| Free cash flow margin | 21.94% | (10,901.00%) | 0.00% |
| Return on equity | 18.40% | (5.47%) | (50.12%) |
| Return on assets | 10.46% | (5.15%) | (45.60%) |
| Return on invested capital | 85.21% | (34.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack